These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous lupus erythematosus induced by infliximab. High WA; Muldrow ME; Fitzpatrick JE J Am Acad Dermatol; 2005 Apr; 52(4):E5. PubMed ID: 15793503 [No Abstract] [Full Text] [Related]
3. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Schneider SW; Staender S; Schlüter B; Luger TA; Bonsmann G Arch Dermatol; 2006 Jan; 142(1):115-6. PubMed ID: 16415403 [No Abstract] [Full Text] [Related]
4. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists. Williams VL; Cohen PR Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984 [TBL] [Abstract][Full Text] [Related]
5. Subacute lupus erythematosus during treatment with golimumab for seronegative rheumatoid arthritis. Brunasso AM; Aberer W; Massone C Lupus; 2014 Feb; 23(2):201-3. PubMed ID: 24356614 [TBL] [Abstract][Full Text] [Related]
10. Drug-induced lupus after treatment with infliximab in rheumatoid arthritis. Benucci M; Li Gobbi F; Fossi F; Manfredi M; Del Rosso A J Clin Rheumatol; 2005 Feb; 11(1):47-9. PubMed ID: 16357696 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus induced by golimumab therapy. Al Izzi M; Reda A Int J Rheum Dis; 2017 Dec; 20(12):2159-2161. PubMed ID: 27458030 [No Abstract] [Full Text] [Related]
12. Subacute cutaneous lupus erythematosus in the course of rheumatoid arthritis: a relationship with TNF-α antagonists and rituximab therapy? Lis-Święty A; Brzezińska-Wcisło L; Widuchowska M; Kucharz E Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):443-6. PubMed ID: 23537059 [TBL] [Abstract][Full Text] [Related]
13. Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. van Rijthoven AW; Bijlsma JW; Canninga-van Dijk M; Derksen RH; van Roon JA Rheumatology (Oxford); 2006 Oct; 45(10):1317-9. PubMed ID: 16844698 [No Abstract] [Full Text] [Related]
15. Chilblain lupus during treatment with golimumab for rheumatoid arthritis. Urata Y; Honda T; Kaku Y; Kabashima K J Dermatol; 2019 Sep; 46(9):e314-e315. PubMed ID: 30951207 [No Abstract] [Full Text] [Related]
16. Infliximab induced chilblain lupus in a patient with rheumatoid arthritis. Richez C; Dumoulin C; Schaeverbeke T J Rheumatol; 2005 Apr; 32(4):760-1. PubMed ID: 15801042 [No Abstract] [Full Text] [Related]
17. Drug-induced lupus-like syndrome in ankylosing spondylitis treated with infliximab. Mounach A; Ghazi M; Nouijai A; Ghozlani I; Achemlal L; Bezza A; El Maghraoui A Clin Exp Rheumatol; 2008; 26(6):1116-8. PubMed ID: 19210883 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Favalli EG; Sinigaglia L; Varenna M; Arnoldi C Lupus; 2002; 11(11):753-5. PubMed ID: 12475006 [TBL] [Abstract][Full Text] [Related]
19. Anti-TNF-alpha-induced systemic lupus syndrome. Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321 [TBL] [Abstract][Full Text] [Related]
20. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature. Shovman O; Tamar S; Amital H; Watad A; Shoenfeld Y Clin Rheumatol; 2018 Feb; 37(2):563-568. PubMed ID: 29063464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]